MARKET

RWLK

RWLK

Rewalk Robotics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9200
+0.0291
+3.27%
After Hours: 0.9000 -0.02 -2.17% 19:06 05/19 EDT
OPEN
0.8769
PREV CLOSE
0.8909
HIGH
0.9300
LOW
0.8750
VOLUME
206.57K
TURNOVER
0
52 WEEK HIGH
2.780
52 WEEK LOW
0.8500
MARKET CAP
57.51M
P/E (TTM)
-3.3861
1D
5D
1M
3M
1Y
5Y
BRIEF-ReWalk Robotics Confirms Receipt Of Director Candidate Nominations From Creative Value Capital
reuters.com · 14h ago
ReWalk Robotics Confirms Receipt of Director Candidate Nominations from Creative Value Capital
Shareholders Are Not Required to Take Action at This Time MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, May 19, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical te...
GlobeNewswire · 16h ago
BRIEF-ReWalk Robotics Posts Quarterly Loss Per Share $0.07
reuters.com · 6d ago
ReWalK GAAP EPS of -$0.07, revenue of $0.88M
ReWalK press release (NASDAQ:RWLK): Q1 GAAP EPS of -$0.07. Revenue of $0.88M (-33.3% Y/Y). As of March 31, 2022, ReWalk had $82.6M in cash on its balance sheet.
Seekingalpha · 6d ago
ReWalk Robotics Q1 EPS $(0.07) Misses $(0.05) Estimate, Sales $876.00K Miss $2.20M Estimate
ReWalk Robotics (NASDAQ:RWLK) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. This is a 12.5 percent increase over losses of $(0.08) per share from the
Benzinga · 6d ago
Earnings Reaction History: ReWalk Robotics Ltd, 27.3% Follow-Through Indicator, 8.1% Sensitive
MT Newswires · 6d ago
Notable earnings after Friday's close
LIDR, RWLK For Seeking Alpha's full earnings season calendar, click here.
Seekingalpha · 05/12 21:35
ReWalK Q1 2022 Earnings Preview
ReWalK (NASDAQ:RWLK) is scheduled to announce Q1 earnings results on Friday, May 13th, after market close. The consensus EPS Estimate is -$0.05 (+37.5% Y/Y) and the consensus Revenue Estimate is
Seekingalpha · 05/12 21:35
More
No Data
Learn about the latest financial forecast of RWLK. Analyze the recent business situations of Rewalk Robotics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average RWLK stock price target is 3.500 with a high estimate of 3.500 and a low estimate of 3.500.
High3.500
Average3.500
Low3.500
Current 0.9200
EPS
Actual
Estimate
-0.06-0.04-0.03-0.01
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 58
Institutional Holdings: 3.59M
% Owned: 5.75%
Shares Outstanding: 62.51M
TypeInstitutionsShares
Increased
7
746.85K
New
11
621.47K
Decreased
10
880.04K
Sold Out
7
983.24K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.66%
Healthcare Equipment & Supplies
+1.30%
Key Executives
Non-Executive Chairman/Independent Director
Jeff Dykan
Chief Financial Officer/Chief Accounting Officer
Almog Adar
Vice President
Jeannine Lynch
Director/Chief Executive Officer
Lawrence Jasinski
Director
Joseph Turk
Independent Director
Aryeh Dan
Independent Director
Yohanan Engelhardt
Independent Director
Yasushi Ichiki
Independent Director
John Poduska
Independent Director
Randel Richner
Independent Director
Wayne Weisman
No Data
No Data
About RWLK
ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. ReWalk designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers two ReWalk products: ReWalk Personal and ReWalk Rehabilitation. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities, and is custom fitted for each user. ReWalk Rehabilitation is designed for use by paraplegia patients in the clinical rehabilitation environment, where it provides exercise and therapy.

Webull offers kinds of Rewalk Robotics Ltd stock information, including NASDAQ:RWLK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RWLK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RWLK stock methods without spending real money on the virtual paper trading platform.